BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36757117)

  • 1. The evaluation of the effect of tafluprost on the intraocular pressure of healthy male guinea pigs under different light-and-darkness regimes.
    Armin A; Arfaee F; Ozmaie S; Asghari A
    Vet Med Sci; 2023 May; 9(3):1172-1178. PubMed ID: 36757117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Randomized parallel group study of 0.0015% tafluprost ophthalmic solution in patients with primary open-angle glaucoma or ocular hypertension (comparison with 0.005% latanoprost ophthalmic solution)].
    Ge J; Li X; Sun X; He X; Zhang H
    Zhonghua Yan Ke Za Zhi; 2015 Feb; 51(2):95-102. PubMed ID: 25907999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Twenty-four-Hour Measurement of Intraocular Pressure in Guinea Pigs (Cavia porcellus).
    Ansari-Mood M; Mehdi-Rajaei S; Sadjadi R; Selk-Ghaffari M; Williams DL
    J Am Assoc Lab Anim Sci; 2016 Jan; 55(1):95-7. PubMed ID: 26817986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Twenty-four-hour efficacy of preservative-free tafluprost for open-angle glaucoma patients, assessed by home intraocular pressure (Icare-ONE) and blood-pressure monitoring.
    Cho SY; Kim YY; Yoo C; Lee TE
    Jpn J Ophthalmol; 2016 Jan; 60(1):27-34. PubMed ID: 26411460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 0.0015% preservative-free tafluprost on the equine eye.
    Azimpour S; Emami Alagha H; Faghihi H; Rajaei SM; Shokoohimand A
    Vet Ophthalmol; 2022 Mar; 25(2):173-179. PubMed ID: 34806805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
    Ota T; Murata H; Sugimoto E; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of topical administration of tafluprost and combination of tafluprost and timolol or tafluprost and betaxolol on Schirmer tear test, intraocular pressure, and pupil size in clinically healthy dogs.
    Shokoohimand A; Arfaee F; Asghari A; Khaksar E
    Int Ophthalmol; 2020 Oct; 40(10):2585-2592. PubMed ID: 32504308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 24-Hour Efficacy and Ocular Surface Health with Preservative-Free Tafluprost Alone and in Conjunction with Preservative-Free Dorzolamide/Timolol Fixed Combination in Open-Angle Glaucoma Patients Insufficiently Controlled with Preserved Latanoprost Monotherapy.
    Konstas AG; Boboridis KG; Kapis P; Marinopoulos K; Voudouragkaki IC; Panayiotou D; Mikropoulos DG; Pagkalidou E; Haidich AB; Katsanos A; Quaranta L
    Adv Ther; 2017 Jan; 34(1):221-235. PubMed ID: 27913991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of Open-Angle Glaucoma and Ocular Hypertension with Preservative-Free Tafluprost/Timolol Fixed-Dose Combination Therapy: The VISIONARY Study.
    Oddone F; Tanga L; Kóthy P; Holló G;
    Adv Ther; 2020 Apr; 37(4):1436-1451. PubMed ID: 32072493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized clinical trial of the efficacy and safety of preservative-free tafluprost and timolol in patients with open-angle glaucoma or ocular hypertension.
    Chabi A; Varma R; Tsai JC; Lupinacci R; Pigeon J; Baranak C; Noble L; Lines C; Ho TW
    Am J Ophthalmol; 2012 Jun; 153(6):1187-96. PubMed ID: 22310086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of tafluprost in normal-tension glaucoma with intraocular pressure of 16 mmHg or less.
    Nakano T; Yoshikawa K; Kimura T; Suzumura H; Nanno M; Noro T
    Jpn J Ophthalmol; 2011 Nov; 55(6):605-13. PubMed ID: 21874307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular Pressure, Tear Production, and Ocular Echobiometry in Guinea Pigs (Cavia porcellus).
    Rajaei SM; Mood MA; Sadjadi R; Azizi F
    J Am Assoc Lab Anim Sci; 2016; 55(4):475-9. PubMed ID: 27423156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of Ocular Pulse Amplitude Lowering Effects of Preservative-Free Tafluprost and Preservative-Free Dorzolamide-Timolol Fixed Combination Eyedrops.
    Seo du R; Ha SJ
    Biomed Res Int; 2015; 2015():435874. PubMed ID: 26557671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Ocular Pulse Amplitude-Lowering Effects of Tafluprost and Latanoprost by Dynamic Contour Tonometry.
    Park SH; Yoo SH; Ha SJ
    J Ocul Pharmacol Ther; 2015 Dec; 31(10):617-22. PubMed ID: 26348718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 6-month study comparing efficacy, safety, and tolerability of the preservative-free fixed combination of tafluprost 0.0015% and timolol 0.5% versus each of its individual preservative-free components.
    Pfeiffer N; Traverso CE; Lorenz K; Saarela V; Liinamaa J; Uusitalo H; Astakhov Y; Boiko E; Ropo A;
    Adv Ther; 2014 Dec; 31(12):1228-46. PubMed ID: 25447269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IOP-lowering efficacy and tolerability of preservative-free tafluprost 0.0015% among patients with ocular hypertension or glaucoma.
    Hommer A; Mohammed Ramez O; Burchert M; Kimmich F
    Curr Med Res Opin; 2010 Aug; 26(8):1905-13. PubMed ID: 20553122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of country-level data from the VISIONARY study examining treatment outcomes with preservative-free tafluprost/timolol fixed-dose combination therapy.
    Holló G; Kirwan J; Lopez-Lopez F; Zimina M; Fassari C; Oddone F;
    Curr Med Res Opin; 2022 Jul; 38(7):1189-1201. PubMed ID: 35621005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Twenty-four-hour ocular hypotensive effects of 0.0015% tafluprost and 0.005% latanoprost in healthy subjects.
    Mochizuki H; Itakura H; Yokoyama T; Takamatsu M; Kiuchi Y
    Jpn J Ophthalmol; 2010 Jul; 54(4):286-90. PubMed ID: 20700794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adjunctive use of tafluprost with timolol provides additive effects for reduction of intraocular pressure in patients with glaucoma.
    Egorov E; Ropo A;
    Eur J Ophthalmol; 2009; 19(2):214-22. PubMed ID: 19253237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective Observational Post-Marketing Study of Tafluprost for Glaucoma and Ocular Hypertension: Effectiveness and Treatment Persistence.
    Kuwayama Y; Hashimoto M; Kakegawa R; Nomura A; Shimada F
    Adv Ther; 2017 Jun; 34(6):1411-1425. PubMed ID: 28502035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.